USPH Short Long Term Debt Total from 2010 to 2024
| USPH Stock | USD 102.57 2.22 2.21% |
Short and Long Term Debt Total | First Reported 1992-09-30 | Previous Quarter 258.6 M | Current Value 256.4 M | Quarterly Volatility 74.1 M |
Check US Physicalrapy financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among USPH main balance sheet or income statement drivers, such as Interest Expense of 9.8 M, Total Revenue of 635 M or Gross Profit of 117.6 M, as well as many exotic indicators such as Price To Sales Ratio of 2.99, Dividend Yield of 0.0194 or PTB Ratio of 4.71. USPH financial statements analysis is a perfect complement when working with US Physicalrapy Valuation or Volatility modules.
USPH | Short Long Term Debt Total |
Latest US Physicalrapy's Short Long Term Debt Total Growth Pattern
Below is the plot of the Short Long Term Debt Total of US Physicalrapy over the last few years. It is US Physicalrapy's Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in US Physicalrapy's overall financial position and show how it may be relating to other accounts over time.
| Short Long Term Debt Total | 10 Years Trend |
|
Short Long Term Debt Total |
| Timeline |
USPH Short Long Term Debt Total Regression Statistics
| Arithmetic Mean | 107,915,090 | |
| Geometric Mean | 55,361,503 | |
| Coefficient Of Variation | 95.43 | |
| Mean Deviation | 86,646,908 | |
| Median | 51,823,000 | |
| Standard Deviation | 102,986,150 | |
| Sample Variance | 10606.1T | |
| Range | 294.8M | |
| R-Value | 0.90 | |
| Mean Square Error | 2155.2T | |
| R-Squared | 0.81 | |
| Slope | 20,742,291 | |
| Total Sum of Squares | 148486.1T |
USPH Short Long Term Debt Total History
About US Physicalrapy Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include US Physicalrapy income statement, its balance sheet, and the statement of cash flows. US Physicalrapy investors use historical funamental indicators, such as US Physicalrapy's Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Although US Physicalrapy investors may use each financial statement separately, they are all related. The changes in US Physicalrapy's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on US Physicalrapy's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on US Physicalrapy Financial Statements. Understanding these patterns can help to make the right decision on long term investment in US Physicalrapy. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Short and Long Term Debt Total | 258.6 M | 271.5 M |
Currently Active Assets on Macroaxis
When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:Check out the analysis of US Physicalrapy Correlation against competitors. For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for USPH Stock analysis
When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is US Physicalrapy's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.19) | Dividend Share 1.73 | Earnings Share 1.16 | Revenue Per Share 41.242 | Quarterly Revenue Growth 0.048 |
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.